Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1

Thymic epithelial tumors occur in 1–5% of patients with multiple endocrine neoplasia type 1 (MEN 1). Majority of these thymic epithelial tumors are thymic carcinoids and patients with thymoma in MEN 1 is rare. Furthermore, thymoma with neuroendocrine differentiation was also rarely reported. Herein,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Masaki, Ichiki, Nobuhiko, Ayabe, Takanori, Tanaka, Hiroyuki, Kataoka, Hiroaki, Nakamura, Kunihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400497/
https://www.ncbi.nlm.nih.gov/pubmed/28458876
http://dx.doi.org/10.1093/jscr/rjx071
_version_ 1783230853903548416
author Tomita, Masaki
Ichiki, Nobuhiko
Ayabe, Takanori
Tanaka, Hiroyuki
Kataoka, Hiroaki
Nakamura, Kunihide
author_facet Tomita, Masaki
Ichiki, Nobuhiko
Ayabe, Takanori
Tanaka, Hiroyuki
Kataoka, Hiroaki
Nakamura, Kunihide
author_sort Tomita, Masaki
collection PubMed
description Thymic epithelial tumors occur in 1–5% of patients with multiple endocrine neoplasia type 1 (MEN 1). Majority of these thymic epithelial tumors are thymic carcinoids and patients with thymoma in MEN 1 is rare. Furthermore, thymoma with neuroendocrine differentiation was also rarely reported. Herein, we report a 68-year-old man having type B3 thymoma with neuroendocrine differentiation in MEN 1 and to the best of our knowledge this is the first such case ever reported.
format Online
Article
Text
id pubmed-5400497
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-54004972017-04-28 Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1 Tomita, Masaki Ichiki, Nobuhiko Ayabe, Takanori Tanaka, Hiroyuki Kataoka, Hiroaki Nakamura, Kunihide J Surg Case Rep Case Report Thymic epithelial tumors occur in 1–5% of patients with multiple endocrine neoplasia type 1 (MEN 1). Majority of these thymic epithelial tumors are thymic carcinoids and patients with thymoma in MEN 1 is rare. Furthermore, thymoma with neuroendocrine differentiation was also rarely reported. Herein, we report a 68-year-old man having type B3 thymoma with neuroendocrine differentiation in MEN 1 and to the best of our knowledge this is the first such case ever reported. Oxford University Press 2017-04-04 /pmc/articles/PMC5400497/ /pubmed/28458876 http://dx.doi.org/10.1093/jscr/rjx071 Text en Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author 2017. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Tomita, Masaki
Ichiki, Nobuhiko
Ayabe, Takanori
Tanaka, Hiroyuki
Kataoka, Hiroaki
Nakamura, Kunihide
Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
title Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
title_full Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
title_fullStr Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
title_full_unstemmed Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
title_short Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
title_sort thymoma (world health organization type b3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400497/
https://www.ncbi.nlm.nih.gov/pubmed/28458876
http://dx.doi.org/10.1093/jscr/rjx071
work_keys_str_mv AT tomitamasaki thymomaworldhealthorganizationtypeb3withneuroendocrinedifferentiationinmultipleendocrineneoplasiatype1
AT ichikinobuhiko thymomaworldhealthorganizationtypeb3withneuroendocrinedifferentiationinmultipleendocrineneoplasiatype1
AT ayabetakanori thymomaworldhealthorganizationtypeb3withneuroendocrinedifferentiationinmultipleendocrineneoplasiatype1
AT tanakahiroyuki thymomaworldhealthorganizationtypeb3withneuroendocrinedifferentiationinmultipleendocrineneoplasiatype1
AT kataokahiroaki thymomaworldhealthorganizationtypeb3withneuroendocrinedifferentiationinmultipleendocrineneoplasiatype1
AT nakamurakunihide thymomaworldhealthorganizationtypeb3withneuroendocrinedifferentiationinmultipleendocrineneoplasiatype1

Ejemplares similares